Table 4 CPIC Rating and IGNITE Member Sites’ use of PGx gene testing for Research, Clinical Reporting and Billing/Reimbursement Methods (range and average number of genes tested)
PGx Genes | Used in Research Mean per site (range) | Used Clinically Mean per site (range) | Finances | ||
|---|---|---|---|---|---|
Billing 3rd party | Billing patients | Institutional support | |||
CPIC A/B (N= 17) | 6.67 (0 – 17) | 5.53 (1 – 16) | 0.93 (0 – 13) | 2.66 (0 – 13) | 4.13 (0 – 16) |
CPIC C/D (N = 8) | 2.8 (0 – 8) | 0.53 (0 – 5)a | 0.2 (0 – 3)b | 0.2 (0 – 3)b | 0.63 (0 – 6)a |
No CPIC rating (N = 15) | 3.47 (3 – 15) | 0.87 (0 – 6) | 0.33 (0 – 5)b | 0.33 (0 – 5)b | 1 (0 – 6) |